Mechanistically, we observed that it could upregulate the expression of platelet-derived growth factor receptor beta (PDGFRB) and activate PI3K/AKT signaling pathway, thereby promoting the proliferation, invasion, and migration of ovarian cancer cells. Here, PDGFRB is linked to ovarian carcinoma.